 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Protagonist Therapeutics Inc (PTGX)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-12-03 Purchase | 2019-12-03 6:46 pm | Protagonist Therapeutics Inc | PTGX | Giraudo Bryan Director | 8,000 | $5.702 | $45,620 | 8,000 (Direct Indirect) | View |
| 2019-12-03 Purchase | 2019-12-03 6:32 pm | Protagonist Therapeutics Inc | PTGX | Gupta Suneel VP | 30,000 | $5.13 | $153,900 | 49,500 (Direct) | View |
| 2019-12-03 Purchase | 2019-12-03 6:11 pm | Protagonist Therapeutics Inc | PTGX | Kalkofen Donald A. CFO | 1,175 | $5.095 | $5,987 | 1,175 (Direct) | View |
| 2019-12-03 Purchase | 2019-12-03 6:10 pm | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 30,000 | $5.617 | $168,500 | 409,824 (Direct) | View |
| 2019-08-06 Sale | 2019-08-08 6:17 pm | Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer | 3,395 | $8.849 | $30,044 | 49,802 (Direct) | View |
| 2019-08-06 Sale | 2019-08-08 6:15 pm | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 10,792 | $8.852 | $95,535 | 374,792 (Direct) | View |
| 2019-02-28 Sale | 2019-03-04 6:35 pm | Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer | 810 | $8.03 | $6,504 | 51,197 (Direct) | View |
| 2019-02-28 Sale | 2019-03-04 6:33 pm | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 2,183 | $8.03 | $17,529 | 383,831 (Direct) | View |
| 2019-02-28 Sale | 2019-03-04 6:29 pm | Protagonist Therapeutics Inc | PTGX | Shames Richard S. Chief Medical Officer | 657 | $8.03 | $5,276 | 32,021 (Direct) | View |
| 2019-02-06 Sale | 2019-02-08 5:37 pm | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 10,909 | $7.738 | $84,410 | 357,264 (Direct) | View |
| 2019-02-06 Sale | 2019-02-08 5:30 pm | Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer | 3,821 | $7.737 | $29,562 | 37,007 (Direct) | View |
| 2019-02-06 Sale | 2019-02-08 5:27 pm | Protagonist Therapeutics Inc | PTGX | Shames Richard S. Chief Medical Officer | 2,778 | $7.741 | $21,506 | 24,178 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-11-26 Exercise | 2019-11-27 2:58 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 4,000 | $1.16 | 18,343 (Direct) | View |
| 2019-11-26 Exercise | 2019-11-27 2:58 pm | N/A 2025-10-28 | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 4,000 | $1.16 | 18,343 (Direct) | View |
| 2019-06-07 Option Award | 2019-06-11 6:33 pm | N/A 2029-06-06 | Protagonist Therapeutics Inc | PTGX | Waddill William D. Director | 12,000 | $11.8 | 12,000 (Direct) | View |
| 2019-06-07 Option Award | 2019-06-11 6:31 pm | N/A 2029-06-06 | Protagonist Therapeutics Inc | PTGX | Williams Lewis T Director | 12,000 | $11.8 | 12,000 (Direct) | View |
| 2019-06-07 Option Award | 2019-06-11 6:29 pm | N/A 2029-06-06 | Protagonist Therapeutics Inc | PTGX | SELICK HAROLD E Director | 12,000 | $11.8 | 12,000 (Direct) | View |
| 2019-06-07 Option Award | 2019-06-11 6:28 pm | N/A 2029-06-06 | Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director | 12,000 | $11.8 | 12,000 (Direct) | View |
| 2019-06-07 Option Award | 2019-06-11 6:26 pm | N/A 2029-06-06 | Protagonist Therapeutics Inc | PTGX | KHOSLA CHAITAN PHD Director | 12,000 | $11.8 | 12,000 (Direct) | View |
| 2019-06-07 Option Award | 2019-06-11 6:20 pm | N/A 2029-06-06 | Protagonist Therapeutics Inc | PTGX | Giraudo Bryan Director | 12,000 | $11.8 | 12,000 (Direct) | View |
| 2019-05-31 Option Award | 2019-06-03 7:40 pm | N/A 2029-05-30 | Protagonist Therapeutics Inc | PTGX | Kalkofen Donald A. CFO | 100,000 | $10.06 | 100,000 (Direct) | View |
| 2019-05-15 Option Award | 2019-05-16 6:43 pm | N/A 2029-05-14 | Protagonist Therapeutics Inc | PTGX | Saks Samuel R Chief Medical Officer | 45,000 | $10.8 | 45,000 (Direct) | View |
| 2019-04-01 Exercise | 2019-04-02 7:19 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | SELICK HAROLD E Director | 3,310 | $1.31 | 0 (Direct) | View |
| 2019-04-01 Exercise | 2019-04-02 7:19 pm | N/A 2019-05-14 | Protagonist Therapeutics Inc | PTGX | SELICK HAROLD E Director | 3,310 | $1.31 | 0 (Direct) | View |
| 2018-05-15 Option Award | 2019-04-02 7:16 pm | N/A 2028-05-14 | Protagonist Therapeutics Inc | PTGX | KHOSLA CHAITAN PHD Director | 3,000 | $6.45 | 3,000 (Direct) | View |
| 2019-02-28 Option Award | 2019-03-04 6:35 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer | 15,000 | $0 | 51,197 (Direct) | View |
| 2019-02-28 Option Award | 2019-03-04 6:35 pm | N/A 2029-02-27 | Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer | 90,000 | $8.02 | 51,197 (Direct) | View |
| 2019-02-28 Option Award | 2019-03-04 6:33 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 28,750 | $0 | 383,831 (Direct) | View |
| 2019-02-28 Option Award | 2019-03-04 6:33 pm | N/A 2029-02-27 | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 172,500 | $8.02 | 383,831 (Direct) | View |
| 2019-02-28 Option Award | 2019-03-04 6:32 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | Saks Samuel R Chief Development Officer | 2,500 | $0 | 15,000 (Direct) | View |
| 2019-02-28 Option Award | 2019-03-04 6:32 pm | N/A 2029-02-27 | Protagonist Therapeutics Inc | PTGX | Saks Samuel R Chief Development Officer | 15,000 | $8.02 | 15,000 (Direct) | View |
| 2019-02-28 Option Award | 2019-03-04 6:29 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | Shames Richard S. Chief Medical Officer | 8,500 | $0 | 32,021 (Direct) | View |
| 2019-02-28 Option Award | 2019-03-04 6:29 pm | N/A 2029-02-27 | Protagonist Therapeutics Inc | PTGX | Shames Richard S. Chief Medical Officer | 51,000 | $8.02 | 32,021 (Direct) | View |
| 2019-02-28 Option Award | 2019-03-04 6:27 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | Gupta Suneel VP | 7,500 | $0 | 45,000 (Direct) | View |
| 2019-02-28 Option Award | 2019-03-04 6:27 pm | N/A 2029-02-27 | Protagonist Therapeutics Inc | PTGX | Gupta Suneel VP | 45,000 | $8.02 | 45,000 (Direct) | View |
| 2019-01-15 Exercise | 2019-01-16 6:42 pm | N/A 2029-01-14 | Protagonist Therapeutics Inc | PTGX | Gupta Suneel VP | 110,000 | $7.38 | 110,000 (Direct) | View |
| 2019-01-11 Exercise | 2019-01-14 7:00 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 22,344 | $1.16 | 22,343 (Direct) | View |
| 2019-01-11 Exercise | 2019-01-14 7:00 pm | N/A 2025-10-28 | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 22,344 | $1.16 | 22,343 (Direct) | View |
| 2018-08-15 Option Award | 2018-08-17 8:29 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | O'Neil Thomas P. CFO | 21,100 | $0 | 14,050 (Direct) | View |
| 2018-08-15 Option Award | 2018-08-17 8:29 pm | N/A 2028-08-14 | Protagonist Therapeutics Inc | PTGX | O'Neil Thomas P. CFO | 14,050 | $8.58 | 14,050 (Direct) | View |
| 2018-08-15 Option Award | 2018-08-17 8:28 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | Shames Richard S. Chief Medical Officer | 18,750 | $0 | 12,500 (Direct) | View |
| 2018-08-15 Option Award | 2018-08-17 8:28 pm | N/A 2028-08-14 | Protagonist Therapeutics Inc | PTGX | Shames Richard S. Chief Medical Officer | 12,500 | $8.58 | 12,500 (Direct) | View |
| 2018-08-15 Option Award | 2018-08-17 8:25 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 82,050 | $0 | 54,700 (Direct) | View |
| 2018-08-15 Option Award | 2018-08-17 8:25 pm | N/A 2028-08-14 | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 54,700 | $8.58 | 54,700 (Direct) | View |
| 2018-08-15 Option Award | 2018-08-17 8:22 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer | 25,800 | $0 | 17,200 (Direct) | View |
| 2018-08-15 Option Award | 2018-08-17 8:22 pm | N/A 2028-08-14 | Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer | 17,200 | $8.58 | 17,200 (Direct) | View |
| 2018-07-12 Gift | 2018-07-13 6:36 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | PATEL DINESH V PH D CEO | 2,000 | $0 | 263,779 (Direct) | View |
| 2018-05-29 Option Award | 2018-06-12 6:55 pm | N/A 2028-05-28 | Protagonist Therapeutics Inc | PTGX | Williams Lewis T Director | 12,000 | $6.98 | 12,000 (Direct) | View |
| 2018-05-29 Option Award | 2018-06-12 6:52 pm | N/A 2028-05-28 | Protagonist Therapeutics Inc | PTGX | Waddill William D. Director | 12,000 | $6.98 | 12,000 (Direct) | View |
| 2018-05-29 Option Award | 2018-06-12 6:50 pm | N/A 2028-05-28 | Protagonist Therapeutics Inc | PTGX | Shanafelt Armen Director 10% Owner | 12,000 | $6.98 | 12,000 (Direct) | View |
| 2018-05-29 Option Award | 2018-06-12 6:48 pm | N/A 2028-05-28 | Protagonist Therapeutics Inc | PTGX | SELICK HAROLD E Director | 12,000 | $6.98 | 12,000 (Direct) | View |
| 2018-05-29 Option Award | 2018-06-12 6:43 pm | N/A 2028-05-28 | Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director | 12,000 | $6.98 | 12,000 (Direct) | View |
| 2018-05-29 Option Award | 2018-06-12 6:40 pm | N/A 2028-05-28 | Protagonist Therapeutics Inc | PTGX | KHOSLA CHAITAN PHD Director | 12,000 | $6.98 | 12,000 (Direct) | View |
| 2018-05-29 Option Award | 2018-06-12 6:39 pm | N/A 2028-05-28 | Protagonist Therapeutics Inc | PTGX | Giraudo Bryan Director | 12,000 | $6.98 | 12,000 (Direct) | View |
| 2018-05-31 Option Award | 2018-05-31 6:29 pm | N/A 2028-05-30 | Protagonist Therapeutics Inc | PTGX | Saks Samuel R Chief Development Officer | 50,000 | $7.28 | 50,000 (Direct) | View |